GLP-1 benefits: new data confirms what employees want
National survey findings suggest that employers must consider much more than just coverage of medication to achieve successful, sustainable weight loss benefits design. The right strategy integrates clinical guidance, behavioral health support and ongoing monitoring and outcomes measurement.
Spring clean your benefits program: 3 steps to smarter weight loss support & GLP-1 governance
GLP-1 demand is rising—and so are costs. Learn a 3-part obesity benefits strategy that integrates behavior change, smarter coverage design, and long-term outcomes beyond the scale.
A winning game plan for GLP-1 cost control and long-term obesity management
GLP-1 demand is rising—and so are costs. Learn a 3-part obesity benefits strategy that integrates behavior change, smarter coverage design, and long-term outcomes beyond the scale.
Integrated obesity management: The missing piece in GLP-1 coverage conversations
GLP-1 medications have quickly taken center stage when it comes to talking about obesity care. As demand grows, employers now have to navigate complex decisions around access, cost, and long-term sustainability, often with increasing financial and regulatory demands. As coverage conversations continue to amp up the pressure, it’s easy to default to a focus only […]
Building a scalable, future-ready GLP-1 strategy for employers
Discover how employers can build scalable, sustainable GLP-1 strategies that balance access, outcomes, and cost control amid changing pricing and utilization trends. As conversations about lowering GLP‑1 costs continue to dominate the benefits landscape, optimism is growing. Self-pay pricing agreements and the emergence of oral GLP-1 medications are expected to expand access for individuals. For […]
Balancing GLP-1 access and affordability: key considerations for employers
GLP-1 medications have changed the conversation around weight and chronic condition management faster than almost anything employers have dealt with in recent years. Demand is real. Outcomes matter. And for many employees, these medications can be life changing. At the same time, benefits leaders are staring down rising costs, unpredictable utilization, and pressure to make decisions that will be sustainable over the long term. […]
Take a breath: How employers can navigate new GLP-1 pricing
While the latest GLP-1 pricing headlines offer hope for individuals looking to access these medications at a lower cost, they raise concerns for employers and payers who must navigate utilization, coverage gaps, and budget implications. GLP-1 costs may appear more predictable under the the latest most-favored-nation (MFN) pricing deals. However, the ‘$149 a month’ headlines may create a false […]
Scouting the Future: Building a Championship-Caliber Benefits Strategy
The demand for GLP-1 medications keeps climbing—and so do the costs. As the benefits landscape continues to shift, weight management has become one of the most challenging areas to get right. GLP-1s have redefined what’s possible for metabolic health—but they’ve also introduced new pressures for employers trying to balance impact and affordability. For employers it’s […]
The cost of bias: Why GLP-1 stigma is a risk you can’t afford to ignore
GLP-1 medications have changed the conversation on obesity. But alongside the breakthroughs, a troubling viewpoint keeps surfacing: that taking them is a shortcut or an “easy way out.” That bias is not harmless. It undermines evidence-based care, discourages people from seeking treatment, and drives up costs for employers and health plans. Bias against GLP-1s is […]
How to future-proof your weight-management strategy
Weight-loss medications have taken center stage in obesity and chronic condition care—and they’re not slowing down anytime soon. As new indications emerge and oral versions move closer to market, it’s no surprise that employers are reevaluating their benefit strategies. But many of those strategies focus more on access than what happens next. Medications can be […]